Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Navidea Biopharmaceuticals, Inc. (NAVB : AMEX)

• Company Description    Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $0.77 Daily Weekly Monthly 20 Day Moving Average: 1,071,453 shares Shares Outstanding: 30.30 (millions) Market Capitalization: $23.29 (millions) Beta: 1.38 52 Week High: $2.19 52 Week Low: $0.72 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.60% -2.41% 12 Week -10.60% -3.38% Year To Date -23.12% -8.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4995 BRADENTON AVENUE SUITE 240 - DUBLIN,OH 43017 USA ph: 614-793-7500 fax: 614-793-7522 jkaufman@navidea.com http://www.navidea.com

• General Corporate Information    Officers Alexander L. Cappello - Chairman of the Board of Directors John K. Scott - Vice Chairman of the Board of Directors Michael S. Rosol - Chief Medical Officer Erika L. Eves - Vice President; Finance & Administration Amit Bhalla - Director Peer Information Navidea Biopharmaceuticals, Inc. (ABMD) Navidea Biopharmaceuticals, Inc. (DMDS) Navidea Biopharmaceuticals, Inc. (CPWY.) Navidea Biopharmaceuticals, Inc. (EQUR) Navidea Biopharmaceuticals, Inc. (ECIA) Navidea Biopharmaceuticals, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 63937X202 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 30.30 Most Recent Split Date: 4.00 (0.05:1) Beta: 1.38 Market Capitalization: $23.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 37.13 Price/Cash Flow: - Price / Sales: 43.87 EPS Growth vs. Year Ago Period: 9.09% vs. Previous Quarter: 16.67% Sales Growth vs. Year Ago Period: -77.17% vs. Previous Quarter: -47.92% ROE 03/31/22 - -314.90 12/31/21 - -182.20 09/30/21 - -116.36 ROA 03/31/22 - -131.12 12/31/21 - -126.95 09/30/21 - -114.53 Current Ratio 03/31/22 - - 12/31/21 - 1.02 09/30/21 - 1.87 Quick Ratio 03/31/22 - - 12/31/21 - 0.99 09/30/21 - 1.83 Operating Margin 03/31/22 - - 12/31/21 - -2,209.23 09/30/21 - -1,557.43 Net Margin 03/31/22 - - 12/31/21 - -2,209.23 09/30/21 - -1,557.43 Pre-Tax Margin 03/31/22 - - 12/31/21 - -2,202.07 09/30/21 - -1,555.14 Book Value 03/31/22 - - 12/31/21 - 0.02 09/30/21 - 0.14 Inventory Turnover 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©